CTMX vs UNH · rev $11.7M vs P/E 30, rev $112.03B
CytomX Therapeutics Inc (CTMX) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
CTMX currently screens at market cap $653.1M. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the CTMX and UNH stock pages for the full models.
Not investment advice.